Atlas Trials

Trial in Metastatic Colorectal Cancer With FOLFIRI Plus Aflibercept as First Line Treatment

Clinical trial NCT02624726 · UNKNOWN

Trial details

NCT number
NCT02624726
Sponsor
Hellenic Oncology Research Group
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Colorectal Cancer
Start date
2016-01-01
Primary completion
2018-10-01
Enrollment
31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.